Details for New Drug Application (NDA): 205504
✉ Email this page to a colleague
NDA 205504 describes ESZOPICLONE, which is a drug marketed by Aurobindo Pharma, Chartwell Rx, Dr Reddys, Glenmark Pharms Ltd, Hetero Labs Ltd V, Hikma, Ipca Labs Ltd, Lupin Ltd, Macleods Pharms Ltd, Mylan Pharms Inc, Nostrum Labs Inc, Orbion Pharms, Sun Pharm, and Teva, and is included in fourteen NDAs. It is available from thirty-two suppliers. Additional details are available on the ESZOPICLONE profile page.
The generic ingredient in ESZOPICLONE is eszopiclone. There are twenty drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the eszopiclone profile page.
The generic ingredient in ESZOPICLONE is eszopiclone. There are twenty drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the eszopiclone profile page.
Summary for 205504
| Tradename: | ESZOPICLONE |
| Applicant: | Hetero Labs Ltd V |
| Ingredient: | eszopiclone |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 205504
Suppliers and Packaging for NDA: 205504
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| ESZOPICLONE | eszopiclone | TABLET;ORAL | 205504 | ANDA | Camber Pharmaceuticals, Inc. | 31722-855 | 31722-855-01 | 100 TABLET, FILM COATED in 1 BOTTLE (31722-855-01) |
| ESZOPICLONE | eszopiclone | TABLET;ORAL | 205504 | ANDA | Camber Pharmaceuticals, Inc. | 31722-855 | 31722-855-30 | 30 TABLET, FILM COATED in 1 BOTTLE (31722-855-30) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 1MG | ||||
| Approval Date: | Jan 4, 2024 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 2MG | ||||
| Approval Date: | Jan 4, 2024 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 3MG | ||||
| Approval Date: | Jan 4, 2024 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
